William Brumskine
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Tuberculosis Research and Epidemiology, Vaccine Coverage and Hesitancy, COVID-19 Clinical Research Studies, HIV/AIDS Research and Interventions
Most-Cited Works
- → Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women(2024)373 cited
- → Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults(2021)227 cited
- → Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial(2021)145 cited
- → Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial(2018)96 cited
- → High Asymptomatic Carriage With the Omicron Variant in South Africa(2022)81 cited
- → A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB(2021)62 cited
- → Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk(2022)49 cited
- → Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study(2021)49 cited
- → Annual Tuberculosis Preventive Therapy for Persons With HIV Infection(2021)38 cited
- → Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial(2024)36 cited